Disclosures for "Thrombectomy for the Treatment of Large Core Ischemic Strokes: An Updated Systematic Review and Meta-analysis After the Release of the TESLA and TENSION Trials"
-
Mr. Dibas has nothing to disclose.
-
Dr. Almajali has nothing to disclose.
-
Dr. Ghannam has nothing to disclose.
-
Dr. Galecio-Castillo has nothing to disclose.
-
Abdullah Al Qudah has nothing to disclose.
-
Dr. Khasiyev has nothing to disclose.
-
Mr. Vivanco-Suarez has nothing to disclose.
-
Dr. Rodriguez-Calienes has nothing to disclose.
-
Dr. Shogren has nothing to disclose.
-
Dr. Al Majali has nothing to disclose.
-
Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. Dr. Yoo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Philips. Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Yoo has stock in Insera Therapeutics. Dr. Yoo has stock in Galaxy Therapeutics. Dr. Yoo has stock in Nicolab. The institution of Dr. Yoo has received research support from Medtronic. The institution of Dr. Yoo has received research support from Cerenovus. The institution of Dr. Yoo has received research support from Penumbra. The institution of Dr. Yoo has received research support from Stryker. The institution of Dr. Yoo has received research support from Genentech. Dr. Yoo has a non-compensated relationship as a consultant with Vesalio that is relevant to AAN interests or activities. Dr. Yoo has a non-compensated relationship as a consultant with Zoll Circulation that is relevant to AAN interests or activities.
-
Dr. Samaniego has nothing to disclose.
-
Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
-
Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from IschemiaView. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.